{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:11:49Z","timestamp":1793149909599,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejso.2020.10.014","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T12:26:50Z","timestamp":1602764810000},"page":"804-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up"],"prefix":"10.1016","volume":"47","author":[{"given":"Sabrina","family":"Kahler-Ribeiro-Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-394X","authenticated-orcid":false,"given":"Eleonora","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-988X","authenticated-orcid":false,"given":"Francesca","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-6758","authenticated-orcid":false,"given":"Elisa","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Morigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-1052","authenticated-orcid":false,"given":"Mattia","family":"Intra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Canegallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ratini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4938-3482","authenticated-orcid":false,"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1882-7068","authenticated-orcid":false,"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-170X","authenticated-orcid":false,"given":"Luca","family":"Bottiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-2174","authenticated-orcid":false,"given":"Chiara Maria","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Villanova","family":"Biasuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.10.014_bib1","article-title":"The landmark series: axillary management in breast cancer","author":"Fisher","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.10.014_bib2","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-020-08650-z","article-title":"Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.014_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","article-title":"Pathobiology of preoperative chemotherapy: findings from the national surgical adjuvant breast and bowel (NSABP) protocol B-18","volume":"95","author":"Fisher","year":"2002","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2020.10.014_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.10.014_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/00000478-200009000-00010","article-title":"Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy","volume":"24","author":"Cohen","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.014_bib6","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.014_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.21911","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis","volume":"104","author":"Tan","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.014_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.014_bib9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.10.014_bib10","author":"Network"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.014_bib11","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1245\/s10434-017-6016-y","article-title":"The optimal treatment plan to avoid axillary lymph node dissection in early-stage breast cancer patients differs by surgical strategy and tumor subtype","volume":"24","author":"Pilewskie","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.014_bib12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","article-title":"The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"41","author":"van Nijnatten","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2020.10.014_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.014_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.014_bib15","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.014_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.014_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.014_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.014_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.10.014_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.014_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.014_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.014_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-010-1494-1","article-title":"Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy","volume":"37","author":"Gilardi","year":"2010","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.ejso.2020.10.014_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/91.4.368","article-title":"Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series","volume":"91","author":"Veronesi","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ejso.2020.10.014_bib25","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.0.CO;2-3","article-title":"Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients","volume":"85","author":"Viale","year":"1999","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.ejso.2020.10.014_bib26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.10.014_bib27","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"1980"},{"key":"10.1016\/j.ejso.2020.10.014_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.014_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.014_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2020.10.014_bib31","article-title":"Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer","author":"Piltin","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.10.014_bib32","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1245\/s10434-014-3775-6","article-title":"Implementation of the American college of surgeons Oncology group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?","volume":"21","author":"Mittendorf","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.014_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s13063-018-3021-9","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial","volume":"19","author":"Henke","year":"2018","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.014_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4820-0","article-title":"Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes","volume":"171","author":"Andersson","year":"2018","journal-title":"Breast Canc Res Treat"},{"issue":"18","key":"10.1016\/j.ejso.2020.10.014_bib35","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review","volume":"45","author":"van Deurzen","year":"2009","journal-title":"Eur J Canc"},{"issue":"8","key":"10.1016\/j.ejso.2020.10.014_bib36","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.014_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/SLA.0000000000002313","article-title":"A\u00a0clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can Be eliminated following neoadjuvant systemic therapy","volume":"267","author":"Kuerer","year":"2018","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.10.014_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.10.014_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41523-017-0029-3","article-title":"CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data","volume":"3","author":"Zujewski","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"22","key":"10.1016\/j.ejso.2020.10.014_bib41","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.014_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2007.15.0326","article-title":"Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference","volume":"26","author":"Buchholz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.10.014_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s12254-017-0368-7","article-title":"Asco 2017: highlights in breast cancer","volume":"10","author":"Bartsch","year":"2017","journal-title":"Memo"},{"issue":"32","key":"10.1016\/j.ejso.2020.10.014_bib47","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.40.8369","article-title":"Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27","volume":"30","author":"Mamounas","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.10.014_bib48","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2020.10.014_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.01.018","article-title":"Radiotherapy after primary CHEMotherapy (RAPCHEM): practice variation in a Dutch registration study (BOOG 2010-03)","volume":"145","author":"Boersma","year":"2020","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.10.014_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","article-title":"Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"12","author":"King","year":"2015","journal-title":"Nat Rev Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:37:59Z","timestamp":1760060279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320308465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0748798320308465"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.014","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}